Pesquisar
Lantern Pharma Inc
LTRNAdicionar à lista de desejos
3.970USD
-0.050-1.24%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
44.68MValor de mercado
PerdaP/L TTM
Mais detalhes de Lantern Pharma Inc Empresa
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
Informações de Lantern Pharma Inc
Código da empresaLTRN
Nome da EmpresaLantern Pharma Inc
Data de listagemJun 11, 2020
CEOSharma (Panna L)
Número de funcionários24
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 11
Endereço1920 Mckinney Avenue
CidadeDALLAS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75201
Telefone19722771136
Sitehttps://www.lanternpharma.com/
Código da empresaLTRN
Data de listagemJun 11, 2020
CEOSharma (Panna L)
Executivos da empresa Lantern Pharma Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Panna L. Sharma
Mr. Panna L. Sharma
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David R. Margrave, J.D.
Mr. David R. Margrave, J.D.
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Dr. Kishor G. Bhatia, Ph.D.
Dr. Kishor G. Bhatia, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Donald Jeff Keyser, J.D., Ph.D.
Dr. Donald Jeff Keyser, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. David S. Silberstein, Ph.D.
Dr. David S. Silberstein, Ph.D.
Independent Director
Independent Director
--
--
Dr. Vijay Chandru, Ph.D.
Dr. Vijay Chandru, Ph.D.
Independent Director
Independent Director
--
--
Dr. Maria L. Maccecchini, Ph.D.
Dr. Maria L. Maccecchini, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lee T. Schalop, M.D.
Dr. Lee T. Schalop, M.D.
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Panna L. Sharma
Mr. Panna L. Sharma
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David R. Margrave, J.D.
Mr. David R. Margrave, J.D.
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Dr. Kishor G. Bhatia, Ph.D.
Dr. Kishor G. Bhatia, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Donald Jeff Keyser, J.D., Ph.D.
Dr. Donald Jeff Keyser, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. David S. Silberstein, Ph.D.
Dr. David S. Silberstein, Ph.D.
Independent Director
Independent Director
--
--
Dr. Vijay Chandru, Ph.D.
Dr. Vijay Chandru, Ph.D.
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Lantern Pharma Inc?
Os cinco principais acionistas de Lantern Pharma Inc são: Mr. Panna L. Sharma
Quantas instituições possuem ações da Lantern Pharma Inc (LTRN)?
Em 2026Q1, 78 instituições possuíam ações da Lantern Pharma Inc, com valor de mercado aproximado de 2.65M, representando 23.45% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 119203.00.